Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+7.47%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$56.6B
AUM Growth
+$2.63B
(+4.9%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
970
New
110
Increased
283
Reduced
395
Closed
105
Top Buys
| 1 |
HES
Hess
HES
|
$285M |
| 2 |
3M
MMM
|
$208M |
| 3 |
Bristol-Myers Squibb
BMY
|
$187M |
| 4 |
Dover
DOV
|
$150M |
| 5 |
Waste Management
WM
|
$145M |
Top Sells
| 1 |
CSX Corp
CSX
|
$201M |
| 2 |
Merck
MRK
|
$191M |
| 3 |
Deere & Co
DE
|
$122M |
| 4 |
RB Global
RBA
|
$108M |
| 5 |
ConocoPhillips
COP
|
$106M |
Sector Composition
| 1 | Technology | 28.49% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 10.57% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Noble Corp
NE
$4.54B
| $6.98M | 0.01% |
193,160
+73,160
| +61% | +$2.64M |
|
677
RH
RH
$4.7B
| $6.89M | 0.01% |
20,600
-20,350
| -50% | -$6.81M |
|
678
Moderna
MRNA
$9.78B
| $6.88M | 0.01% |
102,898
-149,555
| -59% | -$9.99M |
|
679
BioNTech
BNTX
$27B
| $6.83M | 0.01% |
+57,500
| New | +$6.83M |
|
680
Arrowhead Research
ARWR
$4.02B
| $6.78M | 0.01% |
350,000
+250,000
| +250% | +$4.84M |
|
681
Tandem Diabetes Care
TNDM
$850M
| $6.77M | 0.01% |
159,604
+94,604
| +146% | +$4.01M |
|
682
Arq
ARQ
$302M
| $6.75M | 0.01% |
1,149,518
+909,518
| +379% | +$5.34M |
|
683
Qorvo
QRVO
$8.61B
| $6.65M | 0.01% |
64,400
-8,200
| -11% | -$847K |
|
684
ProQR Therapeutics
PRQR
$258M
| $6.6M | 0.01% |
3,625,467
| – | – |
|
685
Vertiv
VRT
$47.4B
| $6.58M | 0.01% |
+66,157
| New | +$6.58M |
|
686
89bio
ETNB
$1.32B
| $6.48M | 0.01% |
875,000
+475,000
| +119% | +$3.52M |
|
687
Invesco
IVZ
$9.81B
| $6.39M | 0.01% |
364,169
-2,300
| -0.6% | -$40.4K |
|
688
Epsilon Energy
EPSN
$126M
| $6.22M | 0.01% |
1,061,909
-50,000
| -4% | -$293K |
|
689
Factset
FDS
$14B
| $6.16M | 0.01% |
13,400
+1,800
| +16% | +$828K |
|
|
ABVX
690
Abivax
ABVX
$6.65B
| $6.12M | 0.01% |
530,861
+5,861
| +1% | +$67.5K |
|
691
M&T Bank
MTB
$31.2B
| $6.07M | 0.01% |
34,090
-15,917
| -32% | -$2.84M |
|
692
Veru
VERU
$49.4M
| $6.05M | 0.01% |
786,111
| – | – |
|
693
Paycom
PAYC
$12.6B
| $5.98M | 0.01% |
35,900
+4,800
| +15% | +$800K |
|
694
Oric Pharmaceuticals
ORIC
$1.06B
| $5.89M | 0.01% |
575,000
-205,400
| -26% | -$2.11M |
|
695
Crown Holdings
CCK
$11B
| $5.89M | 0.01% |
61,421
-58,579
| -49% | -$5.62M |
|
696
WillScot Mobile Mini Holdings
WSC
$4.32B
| $5.88M | 0.01% |
+156,403
| New | +$5.88M |
|
697
CyberArk
CYBR
$23.3B
| $5.83M | 0.01% |
20,000
-35,000
| -64% | -$10.2M |
|
|
SLN
698
Silence Therapeutics
SLN
$269M
| $5.82M | 0.01% |
320,000
-280,000
| -47% | -$5.09M |
|
699
HBT Financial
HBT
$828M
| $5.8M | 0.01% |
265,296
-308,354
| -54% | -$6.75M |
|
700
Globe Life
GL
$11.3B
| $5.79M | 0.01% |
54,700
-25,800
| -32% | -$2.73M |
|